# FDA Inspection 1204029 - Danny Bega, M.D. - April 17, 2023

Source: https://www.keypedia.com/records/fda_inspections/danny-bega-md/3ba5d7aa-4ddf-452d-97de-01f4fb767241
Source feed: FDA_Inspections

> FDA Inspection 1204029 for Danny Bega, M.D. on April 17, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1204029
- Company Name: Danny Bega, M.D.
- Inspection Date: 2023-04-17
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

Company: https://www.keypedia.com/companies/danny-bega-md/7515aba5-e05f-4f34-a46f-77878a9a6a91

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c